Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.44 | 24.00 |
| PEG Ratio (TTM) | -0.88 | -2.91 |
| P/S Ratio (TTM) | 4.84 | 9.64 |
| P/B Ratio (TTM) | 0.99 | 19.79 |
| P/FCF Ratio (TTM) | 19.03 | 21.23 |
| Price to 5YR AVG Earnings Ratio | 10.32 | 31.75 |
| Price to 5YR AVG FCF Ratio | -7.46 | 26.61 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.05% | 13.73% |
| ROE (TTM) | 11.66% | 61.74% |
| Net Profit Margin (TTM) | 57.33% | 33.03% |
| ROIC 5YR AVG | 6.32% | 40.51% |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.89% | 9.02% | 14.66% |
| Revenue | 22.06% | 66.75% | 49.66% |
| Net Income | -9.83% | 61.75% | 46.00% |
| Cash Flow | -47.22% | 26.65% | 124.06% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 2.79 |
| Quick Ratio (TTM) | 1.17 | 2.35 |
| D/E Ratio (TTM) | 1.31 | 1.43 |
| Interest Coverage (TTM) | 2.24 | 17.89 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 0.82 | 5.68 |
| LTL to 5YR AVG FCF | -8.93 | 3.22 |
| Shares Outstanding Growth 5YR AVG | 31.85% | 55.21% |